EVE Health Group Limited (EVE) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.242x

Based on the latest financial reports, EVE Health Group Limited (EVE) has a cash flow conversion efficiency ratio of -0.242x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-907.94K ≈ $-642.42K USD) by net assets (AU$3.76 Million ≈ $2.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see EVE Health Group Limited stock valuation for the company's overall valuation and market capitalisation.

EVE Health Group Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how EVE Health Group Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

EVE Health Group Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of EVE Health Group Limited ranked by their cash flow conversion efficiency. Explore EVE Health Group Limited cash flow quality index to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Indo Komoditi Korpora Tbk PT
JK:INCF
0.024x
Gencell Ltd
TA:GNCL
-0.577x
EURO MANGANESE CDI/1
F:E06A
0.149x
NETCLASS TECHNOLOGY INC Class A Ordinary Shares
NASDAQ:NTCL
-0.535x
HB Stockholdings Limited
NSE:HBSL
-0.126x
Creative Global Technology Holdings Limited Ordinary Shares
NASDAQ:CGTL
-0.001x
Decent Holding Inc Ordinary Shares
NASDAQ:DXST
-0.411x
Dimet (Siam) Public Company Limited
BK:DIMET
-0.055x

Annual Cash Flow Conversion Efficiency for EVE Health Group Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of EVE Health Group Limited from 2004 to 2025. View EVE Health Group Limited (EVE) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$3.55 Million
≈ $2.51 Million
AU$-1.62 Million
≈ $-1.14 Million
-0.455x +49.72%
2024-06-30 AU$1.22 Million
≈ $866.05K
AU$-1.11 Million
≈ $-783.25K
-0.904x -71.38%
2023-06-30 AU$3.12 Million
≈ $2.21 Million
AU$-1.65 Million
≈ $-1.17 Million
-0.528x +3.00%
2022-06-30 AU$6.93 Million
≈ $4.91 Million
AU$-3.77 Million
≈ $-2.67 Million
-0.544x -146.98%
2021-06-30 AU$10.19 Million
≈ $7.21 Million
AU$-2.24 Million
≈ $-1.59 Million
-0.220x +9.31%
2020-06-30 AU$12.99 Million
≈ $9.19 Million
AU$-3.16 Million
≈ $-2.23 Million
-0.243x -32.63%
2019-06-30 AU$5.85 Million
≈ $4.14 Million
AU$-1.07 Million
≈ $-757.90K
-0.183x -67.12%
2018-06-30 AU$7.38 Million
≈ $5.22 Million
AU$-808.76K
≈ $-572.25K
-0.110x +45.55%
2017-06-30 AU$2.78 Million
≈ $1.97 Million
AU$-558.99K
≈ $-395.52K
-0.201x +45.42%
2016-06-30 AU$1.75 Million
≈ $1.24 Million
AU$-645.76K
≈ $-456.92K
-0.369x -305.44%
2015-06-30 AU$2.64 Million
≈ $1.87 Million
AU$-240.46K
≈ $-170.14K
-0.091x -368.93%
2014-06-30 AU$8.11 Million
≈ $5.74 Million
AU$-157.19K
≈ $-111.23K
-0.019x +79.66%
2013-06-30 AU$8.18 Million
≈ $5.79 Million
AU$-779.82K
≈ $-551.77K
-0.095x -39.15%
2012-06-30 AU$23.04 Million
≈ $16.30 Million
AU$-1.58 Million
≈ $-1.12 Million
-0.069x +64.89%
2011-06-30 AU$25.64 Million
≈ $18.14 Million
AU$-5.00 Million
≈ $-3.54 Million
-0.195x -117.47%
2010-06-30 AU$25.15 Million
≈ $17.79 Million
AU$-2.26 Million
≈ $-1.60 Million
-0.090x +29.17%
2009-06-30 AU$22.93 Million
≈ $16.23 Million
AU$-2.91 Million
≈ $-2.06 Million
-0.127x -29.01%
2008-06-30 AU$25.64 Million
≈ $18.14 Million
AU$-2.52 Million
≈ $-1.78 Million
-0.098x -34.67%
2007-06-30 AU$18.78 Million
≈ $13.29 Million
AU$-1.37 Million
≈ $-969.08K
-0.073x -104.92%
2006-06-30 AU$5.98 Million
≈ $4.23 Million
AU$-212.78K
≈ $-150.56K
-0.036x +46.18%
2005-06-30 AU$2.22 Million
≈ $1.57 Million
AU$-146.87K
≈ $-103.92K
-0.066x +70.17%
2004-06-30 AU$251.35K
≈ $177.84K
AU$-55.71K
≈ $-39.42K
-0.222x --

About EVE Health Group Limited

AU:EVE Australia Packaged Foods
Market Cap
$4.20 Million
AU$5.94 Million AUD
Market Cap Rank
#29005 Global
#1586 in Australia
Share Price
AU$0.02
Change (1 day)
-5.56%
52-Week Range
AU$0.01 - AU$0.04
All Time High
AU$0.04
About

EVE Health Group Limited, together with its subsidiaries, engages in the development, retail, and commercialization of health and wellness, and pharmaceutical products. The company lead product is Dyspro, a proprietary pharmaceutical-grade formulation to address dysmenorrhea (menstrual pain); and Libbo, a proprietary pharmaceutical-grade oral dissolving film formulation for the treatment of erect… Read more